US Stock MarketDetailed Quotes

VANI Vivani Medical

Watchlist
  • 1.290
  • -0.020-1.53%
Close Nov 1 16:00 ET
71.28MMarket Cap-2804P/E (TTM)

Vivani Medical Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
13.50%-4.8M
35.23%-4.51M
-26.15%-23.7M
33.10%-3.48M
-10.68%-7.7M
-60.92%-5.55M
-119.33%-6.97M
-71.56%-18.79M
-75.84%-5.2M
-6.96M
Net income from continuing operations
17.93%-5.36M
4.42%-6.04M
-84.69%-25.65M
17.27%-6.03M
-576.60%-6.78M
-59.02%-6.53M
-61.01%-6.32M
-8.74%-13.89M
-101.22%-7.28M
--1.42M
Operating gains losses
----
----
--121K
----
----
----
----
----
----
----
Depreciation and amortization
25.00%100K
-8.33%99K
-6.30%357K
-10.91%98K
-29.70%71K
-8.05%80K
30.12%108K
10.43%381K
32.53%110K
--101K
Other non cash items
-61.58%73K
232.26%82K
113.08%904K
227.12%75K
110.15%701K
603.70%190K
-329.63%-62K
-1,002.55%-6.91M
-326.92%-59K
---6.91M
Change In working capital
-119.23%-35K
193.41%993K
-482.54%-1.29M
-3.66%1.79M
-12.05%-2.2M
23.81%182K
-456.71%-1.06M
-22.48%338K
1,488.89%1.86M
---1.97M
-Change in prepaid assets
140.11%448K
463.40%556K
155.46%264K
1,023.42%3.55M
-229.95%-2.02M
-830.83%-1.12M
-150.82%-153K
-566.67%-476K
364.71%316K
---611K
-Change in payables and accrued expense
-137.18%-483K
148.02%437K
-291.28%-1.56M
-214.00%-1.76M
86.20%-187K
386.52%1.3M
-353.48%-910K
143.71%814K
3,048.98%1.54M
---1.36M
Cash from discontinued investing activities
Operating cash flow
13.50%-4.8M
35.23%-4.51M
-26.15%-23.7M
33.10%-3.48M
-10.68%-7.7M
-60.92%-5.55M
-119.33%-6.97M
-71.56%-18.79M
-75.84%-5.2M
---6.96M
Investing cash flow
Cash flow from continuing investing activities
15.91%-37K
-391.89%-182K
-162.43%-887K
-1,712.20%-743K
65.19%-63K
48.84%-44K
-23.33%-37K
40.91%-338K
83.98%-41K
-181K
Net PPE purchase and sale
15.91%-37K
-391.89%-182K
-162.43%-887K
-734.83%-743K
52.63%-63K
48.84%-44K
-23.33%-37K
40.91%-338K
65.23%-89K
---133K
Cash from discontinued investing activities
Investing cash flow
15.91%-37K
-391.89%-182K
-162.43%-887K
-1,712.20%-743K
65.19%-63K
48.84%-44K
-23.33%-37K
40.91%-338K
83.98%-41K
---181K
Financing cash flow
Cash flow from continuing financing activities
1,457.14%109K
13.69M
-99.79%133K
23K
-99.81%103K
-41.67%7K
0
445.52%63.39M
0
55.38M
Net common stock issuance
--112K
--13.69M
731.25%133K
----
----
--0
--0
-99.86%16K
----
----
Proceeds from stock option exercised by employees
-142.86%-3K
--3K
----
----
--103K
--7K
--0
----
----
----
Net other financing activities
----
----
----
----
----
----
----
--63.37M
--0
--55.37M
Cash from discontinued financing activities
Financing cash flow
1,457.14%109K
--13.69M
-99.79%133K
--23K
-99.81%103K
-41.67%7K
--0
445.52%63.39M
--0
--55.38M
Net cash flow
Beginning cash position
-21.43%30.99M
-52.65%21.99M
2,032.32%46.44M
-49.33%26.19M
881.22%33.85M
465.60%39.44M
2,032.32%46.44M
4.66%2.18M
4,294.90%51.68M
--3.45M
Current changes in cash
15.36%-4.73M
228.46%9M
-155.24%-24.45M
19.89%-4.2M
-115.88%-7.66M
-58.59%-5.59M
-246.05%-7M
45,534.02%44.27M
-623.35%-5.24M
--48.24M
Effect of exchange rate changes
--0
---2K
400.00%3K
200.00%6K
0.00%-3K
--0
--0
---1K
--2K
---3K
End cash Position
-22.44%26.26M
-21.43%30.99M
-52.65%21.99M
-52.65%21.99M
-49.33%26.19M
881.22%33.85M
465.60%39.44M
2,032.32%46.44M
2,032.32%46.44M
--51.68M
Free cash flow
13.51%-4.84M
32.97%-4.69M
-28.55%-24.59M
19.45%-4.22M
-8.75%-7.77M
-58.25%-5.59M
-118.43%-7M
-65.97%-19.13M
-63.11%-5.24M
---7.14M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 13.50%-4.8M35.23%-4.51M-26.15%-23.7M33.10%-3.48M-10.68%-7.7M-60.92%-5.55M-119.33%-6.97M-71.56%-18.79M-75.84%-5.2M-6.96M
Net income from continuing operations 17.93%-5.36M4.42%-6.04M-84.69%-25.65M17.27%-6.03M-576.60%-6.78M-59.02%-6.53M-61.01%-6.32M-8.74%-13.89M-101.22%-7.28M--1.42M
Operating gains losses ----------121K----------------------------
Depreciation and amortization 25.00%100K-8.33%99K-6.30%357K-10.91%98K-29.70%71K-8.05%80K30.12%108K10.43%381K32.53%110K--101K
Other non cash items -61.58%73K232.26%82K113.08%904K227.12%75K110.15%701K603.70%190K-329.63%-62K-1,002.55%-6.91M-326.92%-59K---6.91M
Change In working capital -119.23%-35K193.41%993K-482.54%-1.29M-3.66%1.79M-12.05%-2.2M23.81%182K-456.71%-1.06M-22.48%338K1,488.89%1.86M---1.97M
-Change in prepaid assets 140.11%448K463.40%556K155.46%264K1,023.42%3.55M-229.95%-2.02M-830.83%-1.12M-150.82%-153K-566.67%-476K364.71%316K---611K
-Change in payables and accrued expense -137.18%-483K148.02%437K-291.28%-1.56M-214.00%-1.76M86.20%-187K386.52%1.3M-353.48%-910K143.71%814K3,048.98%1.54M---1.36M
Cash from discontinued investing activities
Operating cash flow 13.50%-4.8M35.23%-4.51M-26.15%-23.7M33.10%-3.48M-10.68%-7.7M-60.92%-5.55M-119.33%-6.97M-71.56%-18.79M-75.84%-5.2M---6.96M
Investing cash flow
Cash flow from continuing investing activities 15.91%-37K-391.89%-182K-162.43%-887K-1,712.20%-743K65.19%-63K48.84%-44K-23.33%-37K40.91%-338K83.98%-41K-181K
Net PPE purchase and sale 15.91%-37K-391.89%-182K-162.43%-887K-734.83%-743K52.63%-63K48.84%-44K-23.33%-37K40.91%-338K65.23%-89K---133K
Cash from discontinued investing activities
Investing cash flow 15.91%-37K-391.89%-182K-162.43%-887K-1,712.20%-743K65.19%-63K48.84%-44K-23.33%-37K40.91%-338K83.98%-41K---181K
Financing cash flow
Cash flow from continuing financing activities 1,457.14%109K13.69M-99.79%133K23K-99.81%103K-41.67%7K0445.52%63.39M055.38M
Net common stock issuance --112K--13.69M731.25%133K----------0--0-99.86%16K--------
Proceeds from stock option exercised by employees -142.86%-3K--3K----------103K--7K--0------------
Net other financing activities ------------------------------63.37M--0--55.37M
Cash from discontinued financing activities
Financing cash flow 1,457.14%109K--13.69M-99.79%133K--23K-99.81%103K-41.67%7K--0445.52%63.39M--0--55.38M
Net cash flow
Beginning cash position -21.43%30.99M-52.65%21.99M2,032.32%46.44M-49.33%26.19M881.22%33.85M465.60%39.44M2,032.32%46.44M4.66%2.18M4,294.90%51.68M--3.45M
Current changes in cash 15.36%-4.73M228.46%9M-155.24%-24.45M19.89%-4.2M-115.88%-7.66M-58.59%-5.59M-246.05%-7M45,534.02%44.27M-623.35%-5.24M--48.24M
Effect of exchange rate changes --0---2K400.00%3K200.00%6K0.00%-3K--0--0---1K--2K---3K
End cash Position -22.44%26.26M-21.43%30.99M-52.65%21.99M-52.65%21.99M-49.33%26.19M881.22%33.85M465.60%39.44M2,032.32%46.44M2,032.32%46.44M--51.68M
Free cash flow 13.51%-4.84M32.97%-4.69M-28.55%-24.59M19.45%-4.22M-8.75%-7.77M-58.25%-5.59M-118.43%-7M-65.97%-19.13M-63.11%-5.24M---7.14M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data